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ABSTRACT
Background Paroxysmal kinesigenic choreoathetosis
(PKC) is characterised by recurrent and brief attacks of
involuntary movement, inherited as an autosomal
dominant trait with incomplete penetrance. A PKC locus
has been previously mapped to the pericentromeric
region of chromosome 16 (16p11.2-q12.1), but the
causative gene remains unidentiﬁed.
Methods/results Deep sequencing of this 30 Mb region
enriched with array capture in ﬁve affected individuals
from four Chinese PKC families detected two
heterozygous PRRT2 insertions (c.369dupG and
c.649dupC), producing frameshifts and premature stop
codons (p.S124VfsX10 and p.R217PfsX8, respectively) in
two different families. Sanger sequencing conﬁrmed
these two mutations and revealed a missense PRRT2
mutation (c.859G/A, p.A287T) in one of the two
remaining families. This study also sequenced PRRT2 in
29 sporadic cases affected with PKC and identiﬁed
mutations in 10 cases, including six with the c.649dupC
mutation. Most variants were truncating mutations,
consistent with loss-of-function and haploinsufﬁciency.
Conclusion The present study identiﬁes PRRT2 as the
gene mutated in a subset of PKC, and suggests that PKC
is genetically heterogeneous.
INTRODUCTION
Paroxysmal kinesigenic choreoathetosis (PKC,
OMIM 128200) is the most frequently described
type of paroxysmal dyskinesias disorder and is
characterised by recurrent and brief attacks of
involuntary movement.
1 Familial and sporadic
cases have been described. Familial PKC usually
shows an autosomal dominant inheritance pattern
with incomplete penetrance.
We previously performed linkage and haplotype
analysis in four Chinese families (family 2 and
family 4 with incomplete penetrance) with similar
choreoathetosis clinical symptoms, and all mapped
the disease locus to a region between D16S3093 and
D16S3057 at 16p11.2-q12.1.
2 3 This PKC critical
region was in accordance with other studies.
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However, the causative gene remains unidentiﬁed.
Recently, next generation sequencing has proven to
be effective for discovering novel causal mutations
in inherited diseases.
METHODS
We sequenced the targeted region of linkage (chr16:
27958 387e57529851), containing 237 RefSeq
genes, in ﬁve individuals with PKC and one healthy
control (did not carry the risk haplotype we
previously identiﬁed) from four families in our
previous report linked to this locus. The shotgun
fragment libraries were hybridised to a custom
NimbleGen array targeting the region and the
eluate sequenced on the Illumina HiSeq 2000 plat-
form. On average, 3.0 gigabases of data were
generated per sample, to achieve at least 150-fold
coverage of the mappable region (13 Mb) (details
in supplementary table 1). We focused primarily
Table 1 Mutations in the PRRT2 gene by Sanger sequencing
Sample Mutation Exon
Amino
acid change
SIFT and Polyphen
predictions
Family 1 c.859G/A 2 p.A287T Damaging
Family 2 c.649dupC 2 p.R217PfsX8 e
Family 4 c.369dupG 2 p.S124VfsX10 e
6 c.649dupC 2 p.R217PfsX8 e
11 c.649dupC 2 p.R217PfsX8 e
16 c.649dupC 2 p.R217PfsX8 e
17 c.649dupC 2 p.R217PfsX8 e
18 c.649dupC 2 p.R217PfsX8 e
22 c.1011_1012delCG+
1_9delGTGAGTGGG
3 Splice-site e
26 c.964delG 3 p.V322WfsX15 e
27 c.841T/C 2 p.W281R Damaging
28 c.649dupC 2 p.R217PfsX8 e
29 c.922C/T 3 p.R308C Damaging
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New locion non-synonymous variants, splice site acceptor or donor
variants, and coding insertions or deletions (NS/SS/I) that were
most likely to be pathogenic (supplementary table 2).
RESULTS
A total of 149e160 NS/SS/I variants were detected in 55 genes
per affected individual. After ﬁltering for variants found in
dbSNP129, 1000 Genome Project and the healthy control
sequencing data to remove shared variants, the number of
variants was reduced approximately eightfold. A 0.60 Mb de
novo microdeletion at 16p11.2 was identiﬁed in two sporadic
PKC case reports,
6 7 which suggested loss-of-function mutations
seemed to cause the disorder and narrowed down the candidate
region. Only one gene located in this region of the microdeletion,
PRRT2, which encodes proline-rich transmembrane protein 2,
harboured two heterozygous frameshift insertions in two
families: a cytosine insertion (c.649dupC) in family 2 causing
a frameshift and premature stop codon (p.R217PfsX8); and
a guanine insertion (c.369dupG) in family 4 causing a frameshift
and premature stop codon (p.S124VfsX10). In each family, the
independent heterozygous mutations were indeed present in all
available affected individuals and healthy risk haplotype carries
we previously identiﬁed using Sanger sequencing.
To conﬁrm that mutations in PRRT2 were responsible for
PKC, we screened the whole sequences of PRRT2 gene (exon,
intron, 500 bp upstream of 59UTR and 500 bp downstream of
39UTR) in two other families (targeted genomic sequencing did
not detect mutations likely due to the quality of sample) and 29
new PKC individuals. In family 1 (one of the two remaining
families), a missense mutation (c.859G/A, p.A287T) in PRRT2
completely cosegregated with PKC phenotype, and ﬁve different
mutations were detected in 10 sporadic PKC individuals.
Collectively, seven different mutations were identiﬁed in PRRT2
by a combination of targeted genomic and Sanger sequencing
(table 1, ﬁgure 1). None of these mutations was found in
chromosomes from 192 ethnically matched control individuals.
DISCUSSION
Our results strongly suggest that mutations in PRRT2 are
a cause of PKC. Little is known about PRRT2 or the functions of
its encoded protein. In UniProtKB database, PRRT2 (Q7Z6L0) is
predicted to be a multi-pass membrane protein consisting of an
N-terminal extracellular domain containing a proline-rich
domain and an N-glycosylation site, two transmembrane
domains, and a C-terminal cytoplasmic domain. The N-terminal
extracellular domain of PRRT2 is similar to PRiMA (proline-rich
membrane anchor), which targets acetylcholinesterase to
membrane.
8 In addition, PRRT2 is also highly expressed in brain
(Unigene). Therefore, we speculate that PRRT2 may serve as an
anchor to connect with certain molecular at synapse.
In our Chinese PKC cohort, heterozygous mutations in PRRT2
explain 39.4% (13/33) of cases. Most of the mutations were
predicted to truncate the polypeptide. One mutation was
recurrentdc.649dupCdwhich was present in one family and
six sporadic cases. Haploinsufﬁciency seems to be the most
likely mechanism. Microdeletions of chromosome 16p11.2,
encompassing PRRT2, have been reported in two sporadic PKC
individuals.
6 7 Also, three pathogenic missense mutations iden-
tiﬁed in family 1 and two sporadic cases were present at
a conserved site among different species (supplementary
ﬁgure 1). Different types of mutations may be associated with
different phenotype. Clinical characteristics should be deﬁned
strictly. However, for one family (family 3) linked to the peri-
centromeric region of chromosome 16 and 19 sporadic cases, we
screened the whole sequences of the PRRT2 gene and did not
identify any mutations. It is possible that exonic deletions in
PRRT2 or other mutations in distal gene regulatory sequences, or
an additional causative gene on the same genomic region, are
responsible for PKC. Alternatively, PKC appears to be genetically
heterogeneous,
91 0and further analysis of these cases by exome
sequencing may ﬁnd additional genes.
Interestingly, PKC, benign familial infantile convulsions
(BFIC2, OMIM 605751), infantile seizures and choreoathetosis
(ICCA, OMIM 602066), and rolandic epilepsy with paroxysmal
exercise induced dystonia and writer’s cramp (RE-PED-WC,
OMIM 608105) overlap across a pericentromeric region of
chromosome 16,
11 suggesting that they may be allelic disorders
caused by PRRT2 mutations. Further functional studies of the
PRRT2 gene and these speciﬁc gene mutations are needed to
provide important insights into the pathophysiology of PKC and
other movement disorders.
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